The Hill outlines its healthcare expectations with a GOP Congress, Sanofi's executive shakeup may have an impact on MannKind's Afrezza launch, AstraZeneca's olaparib may have prostate cancer prospects, the FDA granted orphan status to an experimental Merrimack pancreatic cancer drug, and researchers are struggling to get Ebola virus samples.
A Treasury report says the IRS is having trouble identifying who owes it money.
The company is calling the move a withdrawal, as opposed to a recall.
The company, which expects a 9% to 10% sales jump in 2014, says it will split into two independent companies by the middle of next year.
Dudnyk bought San Francisco-based Stratagem, expanding its West Coast presence and adding medical-device marketing expertise, the agency said.
No sector of the healthcare industry is rooting harder for the Supreme Court to overturn the Affordable Care Act completely tomorrow than are medical device companies, which are bracing themselves for a substantial excise tax on their revenues that takes effect next year under the law.
Johnson & Johnson's Ethicon Endo-Surgery partnered with CBS HealthWatch and the American Society of Colon and Rectal Surgeons for a web event broadcast live from EES's booth at the Society's ongoing annual meeting.
Cook Medical launched a third website for physicians and consumers, this time focusing on a suite of tissue repair products.
FDA commissioned the Institute of Medicine to comb through its premarket notification program, a procedure used to expedite certain medical device approvals, the agency announced today.
The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.